Product Information
METOPROLOL TARTRATE 25 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0159 per EA under NDC 72888000400. Its NADAC has been published 248 times since Jan 5, 2022.
FDA first approved this application on Oct 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888000400
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200981FDA Approved
10/28/2014
TE Code
AB
On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 25 MG TAB has been published 248 times since Jan 5, 2022, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0159 per EA |
|---|---|
| All-time high | $0.0194 (Mar 16, 2022) |
| All-time low | $0.0142 (Nov 20, 2024) |
| 52-week high | $0.0177 |
| 52-week low | $0.0159 |
| Median price | $0.0175 |
| Average price | $0.0173 |
| Largest weekly change | -19.3% (Nov 20, 2024) |
| Weeks tracked | 248 |
| Tracking since | Jan 5, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METOPROLOL TARTRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 25 MG TAB, manufactured by Advagen Pharma Ltd., is $0.0159 per EA (NDC 72888000400), effective Sep 30, 2026.
How has the price of METOPROLOL TARTRATE 25 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 25 MG TAB has declined 18.2%. It has been tracked across 248 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 25 MG TAB?
Since Jan 5, 2022, the NADAC for METOPROLOL TARTRATE 25 MG TAB has ranged from a low of $0.0142 (Nov 20, 2024) to a high of $0.0194 (Mar 16, 2022), with a median of $0.0175 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 25 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL TARTRATE 25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL TARTRATE 25 MG TAB?
METOPROLOL TARTRATE 25 MG TAB (NDC 72888000400) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.